Indo Borax & Chemicals reported strong Q1 FY27 results with a 59.31% surge in net profit to Rs 16.25 crore. Operating revenue grew 31.34% to Rs 70.36 crore, supported by high capacity utilization. Alongside the results, management unveiled a detailed Rs 250 crore funding roadmap for its 64.26% stake acquisition in Kronox Lab Sciences, utilizing internal accruals, asset sales, and strategic debt. Investors are focusing on the synergy potential of this integration and the execution of the company’s ambitious multi-year capex plan.
Indo Borax Q1 Profit Climbs 59% on Operational Growth
Net Profit: Rs 16.25 crore (up 59.31% YoY). Operating Revenue: Rs 70.36 crore (up 31.34% YoY).
Reader Takeaway: Strong operational leverage drives profit, but investors must monitor execution of the large-scale Kronox acquisition and capex plan.
What just happened
Indo Borax & Chemicals delivered a robust Q1 FY27 performance, reporting a net profit of Rs 16.25 crore compared to Rs 10.2 crore in the same period last year. Revenue saw a significant uptick of 31.34%, reaching Rs 70.36 crore. EBITDA margins expanded to 28.1%, reflecting improved efficiency and product realizations.
Why this matters
The filing provided comprehensive details on the acquisition of a 64.26% stake in Kronox Lab Sciences. The Rs 250 crore funding strategy relies on internal accruals (~Rs 135 crore), the sale of non-core Mumbai commercial properties (~Rs 50 crore), and debt financing. The move is designed to leverage Kronox’s global distribution network in North America and Europe to scale Indo Borax’s existing product range.
What changes now
Management has outlined a clear capex roadmap. Indo Borax plans to invest Rs 50 crore over 2-3 years for capacity expansion in Boron Oxide and Boric Acid. Simultaneously, Kronox will undergo a phased capex of Rs 110 crore. These investments are projected to support a full-year revenue target of Rs 250-260 crore for Indo Borax in FY27.
Risks to watch
Management explicitly noted that the high EBITDA margins achieved in Q1 may face pressure in coming quarters due to raw material price volatility. Furthermore, the execution of the Kronox capex plan over the next 18-24 months is a critical monitorable, as the company balances debt servicing with operational integration.
What to track next
Watch for the completion of the Mumbai property divestments, which are key to funding the acquisition without straining the balance sheet. Investors should also monitor Q2 performance, which management indicated may be seasonally softer due to monsoon-related impacts.